{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"85","upperLimit":"92","value":"89"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"295"}],"units":"Participants"}],"description":"Complete response rate is defined as the percentage of patients who achieve bone marrow response (defined using the M bone marrow criteria for acute lymphoblastic leukemia (ALL); if M0 to M1 status (blast cells ,5%) was achieved by the end of induction or extended induction, the patient was considered a responder) at the end of induction therapy.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients received induction (Course I), consolidation (Course II), interim maintenance (Course III), delayed intensification (Course IV), and long-term maintenance therapy (Course V). Please see the \"Detailed Description\" section for more information.","id":"OG000","title":"Treatment (Pediatric Regimen)"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to 8 years post-registration","title":"Complete Response Rate","type":"PRIMARY","unitOfMeasure":"percentage of patients"}